Sargent Investment Group, LLC

Position in MTNB — Matinas BioPharma Holdings, Inc.

CIK 1766157 BETHESDA, MD

Position in MTNB

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$6,360

-$1,093 QoQ

Shares Held

12,720

0.0% QoQ

Ownership

0.199%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Sargent Investment Group, LLC holds $8,795,985 across 5 Biotechnology names. MTNB ranks #5 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	179,025	$7,678,382
2	MDWD	MediWound Ltd.	59,481	$958,238
3	ARDX	Ardelyx, Inc.	14,500	$86,855
4	NAGE	Niagen Bioscience, Inc.	15,000	$66,150
5	MTNB	Matinas BioPharma Holdings, Inc. This page	12,720	$6,360

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,360	12,720	0.0%	Shares	Sole	2026-05-11
2025-12-31	$7,453	12,720	-65.3%	Shares	Sole	2026-02-13
2025-09-30	$69,211	36,620	+2.8%	Shares	Sole	2025-11-14
2025-06-30	$31,701	35,620	-14.8%	Shares	Sole	2025-08-14
2025-03-31	$21,736	41,800	-34.9%	Shares	Sole	2025-05-05
2024-12-31	$32,742	64,200	-20.0%	Shares	Sole	2025-01-27
2024-09-30	$284,049	80,240	—	Shares	Sole	2024-11-06
No filing history on record for this holder in this stock.